Latest On-Demand Webinars & Online Events

Cell therapies often involve introduction of genetically transformed cells into a patient. Recently there has been renewed interest in non-viral gene modification for this application as an alternative to lentiviral vectors.

This exclusive Q&A event invites you to ask anything about the world of predatory conferences to our expert speaker.

This talk delves into the fascinating world of aptamers. Aptamers are short single-stranded nucleic acid oligomers, either DNA or RNA, known for their ability to form intricate three-dimensional structures. The development of aptamers relies on SELEX (systematic evolution of ligands by exponential enrichment), a process that allows researchers to fine-tune their characteristics during selection.

An incredible opportunity to ask the Chief Editor of Nature on how to get published in high-ranking journals.

New for 2023, this online event will provide researchers with an opportunity to learn about how spatial biology is helping us to gain a deeper understanding of molecular biology and mechanisms of disease. Speakers will discuss advances in spatial technologies and how they are being applied to provide a more complete picture of cells and complex biological systems in areas such as cancer research and neuroscience.

This webinar will introduce a novel method for parent-of-origin-aware genomic analysis using the long-read capabilities of nanopore sequencing and single-cell DNA template strand sequencing to assign variants to each biological parent with 99% accuracy using only a blood research sample from the child.

In this webinar, you will learn how to extract nuclei from virtually any tissue in just five minutes in an automated and reproducible way.

In this webinar, Dr. Luciane Kagohara from Johns Hopkins Medicine will discuss a novel artificial intelligence method integrating imaging, spatial transcriptomics and single-cell RNA-seq data that has been used to characterize the cell state transitions in pancreatic cancer progression.

This webinar describes how a new platform for high-throughput proteomics was used to identify multiple proteins associated with ovarian cancer. A 22-protein model was derived that discriminates ovarian cancer cases from benign controls with high accuracy.

In this webinar, our expert speaker Dr. Laralynne Przybyla from the University of California San Francisco will focus on her current work at the Laboratory for Genomics Research.